These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10339480)

  • 1. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
    Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M
    Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model.
    Bruno S; Gammaitoni L; Gunetti M; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    J Biol Regul Homeost Agents; 2001; 15(1):38-48. PubMed ID: 11388743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.
    Conneally E; Cashman J; Petzer A; Eaves C
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9836-41. PubMed ID: 9275212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells.
    Piacibello W; Gammaitoni L; Bruno S; Gunetti M; Fagioli F; Cavalloni G; Aglietta M
    J Hematother Stem Cell Res; 2000 Dec; 9(6):945-56. PubMed ID: 11177609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.
    Gan OI; Murdoch B; Larochelle A; Dick JE
    Blood; 1997 Jul; 90(2):641-50. PubMed ID: 9226164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency.
    Novelli EM; Cheng L; Yang Y; Leung W; Ramírez M; Tanavde V; Enger C; Civin CI
    Hum Gene Ther; 1999 Dec; 10(18):2927-40. PubMed ID: 10609654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
    Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
    Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells.
    Denning-Kendall PA; Evely R; Singha S; Chapman M; Bradley BA; Hows JM
    Br J Haematol; 2002 Jan; 116(1):218-28. PubMed ID: 11841420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
    Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells.
    Xu R; Reems JA
    Transfusion; 2001 Feb; 41(2):213-8. PubMed ID: 11239225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
    Piacibello W; Bruno S; Sanavio F; Droetto S; Gunetti M; Ailles L; Santoni de Sio F; Viale A; Gammaitoni L; Lombardo A; Naldini L; Aglietta M
    Blood; 2002 Dec; 100(13):4391-400. PubMed ID: 12453876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
    Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
    Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors.
    Tourino C; Pflumio F; Novault S; Massé A; Guiller M; Bonnet ML; Valteau-Couanet D; Hartmann O; Vainchenker W; Beaujean F; Coulombel L; Turhan AG
    Hematol J; 2001; 2(2):108-16. PubMed ID: 11424003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.